These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 13381567)
1. [Nucleoproteins of the serum in cancerous diseases]. CIMAROSTI L; DEFILLIPPO RA; VISCHI N Acta Unio Int Contra Cancrum; 1956; 12(4):416-9. PubMed ID: 13381567 [No Abstract] [Full Text] [Related]
2. [Reactivating ability of normal and cancerous serum on inactivated alcaline phosphatases]. MOLNAROVA K; MUCHA R; THURZO V Cesk Onkol; 1955; 2(1):38-45. PubMed ID: 13250641 [No Abstract] [Full Text] [Related]
3. [Detection of cancerous cells in the circulating blood]. de BRUX ; ANCLA M Presse Med (1893); 1960 Jul; 68():1397. PubMed ID: 13805423 [No Abstract] [Full Text] [Related]
4. [Incidence of lactic dehydrogenase in the blood of cancerous patients]. LUHRS W; NEGELEIN E Klin Wochenschr; 1956 Feb; 34(5-6):148-9. PubMed ID: 13307885 [No Abstract] [Full Text] [Related]
5. [Determination of reduction properties of blood serum in diagnosis and evaluation of dynamics of neoplasms]. GOLANSKI A Pol Tyg Lek (Wars); 1954 Jul; 9(28):865-70. PubMed ID: 13224530 [No Abstract] [Full Text] [Related]
6. [Polypeptides in blood serum in malignant tumors]. TORBAN MA Med Zhurnal; 1954; 24(3):121-3. PubMed ID: 13244289 [No Abstract] [Full Text] [Related]
7. [Breakdown of arabinose by cancer serum]. DREVON B; ROULLET M C R Seances Soc Biol Fil; 1952 Dec; 146(23-24):1935-8. PubMed ID: 13043095 [No Abstract] [Full Text] [Related]
8. [The serum protein picture in neoplasms]. LESCA S Boll Soc Med Chir Cremona; 1961; 15():47-52. PubMed ID: 14464274 [No Abstract] [Full Text] [Related]
9. [Inhibiting power of fluorescence in cancer serum]. SAIDMAN-LAGADEC C R Soc Fr Gyncol; 1952 Apr; 22(4):176-8. PubMed ID: 14945185 [No Abstract] [Full Text] [Related]
10. [Nucleic acids (thymic and ribonucleic) in blood serum in cancer]. DEFILIPPO RA; VERSARI AP Prensa Med Argent; 1952 Apr; 39(15):736-41. PubMed ID: 14929922 [No Abstract] [Full Text] [Related]
11. [Pentolytic (and aldolasic) action of serum in cancer]. DASTUGUE G; BASTIDE P Ann Biol Clin (Paris); 1955; 13(10-12):570-8. PubMed ID: 13283394 [No Abstract] [Full Text] [Related]
12. [Studies on serum protein of cancer patients. II]. YAMAGUCHI H; NISHIMOTO M; TANAKA Y; ICHIHARA G Gan; 1952 Sep; 43(2-3):78-9. PubMed ID: 12998756 [No Abstract] [Full Text] [Related]
13. [Changes in some serum enzymes during the course of cancer]. OSTEN W Ther Ggw; 1962 Jun; 101():276-84 concl. PubMed ID: 14482576 [No Abstract] [Full Text] [Related]
14. Content and composition of the mucoprotein fraction of human serum (seromucoid) in disease with special reference to hematologic disorders. MOSCHIDES E; STEFANINI M; MAGALINI SI; KISTNER SA J Clin Invest; 1958 Jan; 37(1):127-37. PubMed ID: 13491720 [No Abstract] [Full Text] [Related]
15. [Studies on the serum protein in patients with malignant tumor]. WARABIOKA K Gan; 1955 Sep; 46(2-3):117-20. PubMed ID: 13262294 [No Abstract] [Full Text] [Related]
16. Studies on the polarographic serum reaction. OSTERLIND S Acta Physiol Scand Suppl; 1955; 34(120):1-134. PubMed ID: 13301842 [No Abstract] [Full Text] [Related]
17. Human serum tributyrinase. III. Levels in cancer. HOARE R; TUBA J J Lab Clin Med; 1951 Oct; 38(4):613-6. PubMed ID: 14889043 [No Abstract] [Full Text] [Related]
18. [Changes in some serum enzymes in the course of neoplastic disease]. OSTEN W Ther Ggw; 1962 May; 101():221-33 contd. PubMed ID: 14482577 [No Abstract] [Full Text] [Related]
19. [On the inhibitory action of blood serum from tumor-bearing rats]. WRBA H; RABES H Klin Wochenschr; 1961 Jul; 39():762. PubMed ID: 13786747 [No Abstract] [Full Text] [Related]
20. [On the diagnostic significance of the phenomenon of arrested decoloration of methylene blue by the blood serum of oncological patients]. SARYCHEVA LN; MOROZOVA Ts Lab Delo; 1962 Jun; 8():20-2. PubMed ID: 14497304 [No Abstract] [Full Text] [Related] [Next] [New Search]